Priothera Ltd.
3 known investors
Find your way into Priothera Ltd.
71 people in our graph share verified history with the Priothera Ltd. team — schools, employers, funds. One of them is your warm intro.
Ann Crady Weissunlockedknows Stephan Oehen · together at UC San Diego (overlapped)
×10knows the team · via UC San Diego
knows the team · via University Hospital Zürich
Priothera is a clinical-stage biotech developing mocravimod (an S1P receptor modulator) for hematologic malignancies such as acute myeloid leukemia. The company focuses on drug development for cancer patients undergoing hematopoietic stem cell transplantation.
Founders & leadership
FG
Florent GrosChief Executive Officer and Founder
SO
Stephan OeheninChief Operating Officer and FounderStephan Oehen is a drug developer with over 25 years in biotech and pharmaceutical R&D across autoimmunity, transplantation, inflammation, dermatology, and vaccines, with a background in immunology and prior experience spanning early research through late-stage development and lifecycle management.
BS
Brice SuireChief Financial Officer and Founder
NC
Nigel ClarkChief Business Officer
JH
Jens HasskarlChief Medical Officer
Investors · 3
In the news
Frequently asked questions
- What does Priothera Ltd. do?
- Priothera is a clinical-stage biotech developing mocravimod (an S1P receptor modulator) for hematologic malignancies such as acute myeloid leukemia. The company focuses on drug development for cancer patients undergoing hematopoietic stem cell transplantation.
- Who founded Priothera Ltd.?
- Priothera Ltd. was founded by Florent Gros, Stephan Oehen, Brice Suire.
- Who are Priothera Ltd.'s investors?
- Priothera Ltd.'s investors include Fountain Healthcare Partners, HealthCap, 4see Ventures.